Terbutaline Sulfate Injection
NDC Package 71872-7080-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Terbutaline Sulfate injection is terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). This formulation utilizes a injection delivery system. Marketed by Medical Purchasing Solutions. Llc, this product is identified by NDC 71872-7080 and is authorized under FDA application ANDA078630.

Identification & Billing

NDC Package Code
71872-7080-1
Package Description
1 VIAL in 1 BAG / 1 mL in 1 VIAL
Product Code
71872-7080
11-Digit Billing Format
71872708001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Terbutaline Sulfate
Non-Proprietary Name
Terbutaline Sulfate
Substance Name
Terbutaline Sulfate
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
TERBUTALINE SULFATE 1 mg/mL
Usage Information
Terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). Terbutaline belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.

Regulatory & Marketing

Labeler Name
Medical Purchasing Solutions. Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA078630
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-20-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71872-7080-1 identifies a specific commercial package of 1 vial in 1 bag / 1 ml in 1 vial of Terbutaline Sulfate, a human prescription drug labeled by Medical Purchasing Solutions. Llc. This injection is formulated for subcutaneous use and contains terbutaline sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions. Llc on May 20, 2009. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). Terbutaline belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.

How is this Medical Purchasing Solutions. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872708001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71872-7080-1
11-Digit CMS (5-4-2)
71872-7080-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.